We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
There isn’t enough historical data to display yet.
Filings, earnings, research, and institutional changes — newest first
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
신규 편입 · 포트폴리오 비중 0.13%
신규 편입 · 포트폴리오 비중 0.01%
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $180.93 · 14 analysts
Stored first · Google News · Yahoo Finance (English)
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS) The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect ACCESS Newswire
iRhythm (IRTC) Removed from Conviction List but Rating Remains P - GuruFocus
iRhythm (IRTC) Removed from Conviction List but Rating Remains P GuruFocus
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation ACCESS Newswire
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $157 - Moomoo
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Maintains Target Price $157 Moomoo
iRhythm Technologies (IRTC) Q4 2024 earnings summary - Quartr
iRhythm Technologies (IRTC) Q4 2024 earnings summary Quartr
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $0 | — | — | $219.28M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.97 | — | — | $158.68M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-3.59 | — | — | $427.51M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-2.12 | — | — | $279.98M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 19. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2026. 05. 05. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2026. 05. 02. | Canaccord Genuity | — | Maintain | Buy → Buy | — | Canaccord Genuity: Buy |
| 2026. 05. 02. | JP Morgan | — | Maintain | Overweight → Overweight | — | JP Morgan: Overweight |
| 2026. 05. 01. | Wells Fargo | — | Maintain | Overweight → Overweight | — | Wells Fargo: Overweight |
| 2026. 05. 01. | Evercore ISI Group | — | Maintain | Outperform → Outperform | — | Evercore ISI Group: Outperform |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 599,405 | $70.74M | 0.13% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 52,600 | $6.21M | 0.01% | — | New position |